Vitalhub Corp. VHI

TORONTO, Ontario, July 29, 2026 (GLOBE NEWSWIRE) -- VitalHub Corp. (TSX:VHI) (OTCQX:VHIBF) (the "Company" or "VitalHub") announced today that it will release financial results for the second quarter 2026 ended June 30, 2026 after market close on August 6, 2026. The Company will subsequently hold a conference call on August 7, 2026, at 9:00am EST, hosted by CEO Dan Matlow and CFO Brian Goffenberg with a Q&A session to follow. To register for the conference call please visit the link here. About V

TORONTO, July 13, 2026 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (“VitalHub” or the “Company”) announced today that it has acquired Buddy Healthcare Ltd Oy (“Buddy Healthcare”), a care coordination platform based in Finland. Transaction Details VitalHub has acquired Buddy Healthcare for total up-front consideration of €8.6 million, plus potential performance-based consideration. The purchase price paid at closing was composed of a cash payment of €8.3 million, subject to working

TORONTO, June 26, 2026 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the “Company” or “VitalHub”) announced today the voting results from its annual general meeting of shareholders held virtually on June 26, 2026. All director nominees were elected to the Company’s board of directors and Ernst & Young LLP was appointed as auditors, as further described in the Company’s management information circular dated May 7, 2026. The summary of the results are as follows: Total Shares Voted:

Vitalhub’s latest research updates feature revised CA$2.50 price targets, drawing attention to how analysts are recalibrating expectations without shifting the core valuation view. These changes are being framed as model fine tuning that reflects execution risks and growth opportunities, rather than a wholesale rethink of the stock, with both bullish and bearish voices clustering around similar target levels. As you read on, you will see how to interpret these adjustments and track the...

TORONTO, June 16, 2026 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the “Company” or “VitalHub”) announced today that Novari Health, a VitalHub company, has executed agreements to implement wait list and referral management software technologies at Sunnybrook Health Sciences Centre and across the northern region of British Columbia. Sunnybrook joins hospitals, regional health authorities, and health systems in Canada, Australia and the United Kingdom that have implemented Novari s

As the Canadian market navigates a period of contained inflation and sluggish growth, the Bank of Canada's decision to hold interest rates steady provides a stable backdrop for investors. In this environment, growth companies with high insider ownership can be particularly appealing, as they often indicate strong confidence from those who know the business best.

Vitalhub’s latest analyst update trims its fair value estimate from CA$12.63 to CA$12.33, pointing to a slightly more tempered view of the stock’s potential upside. Recent research has also cut some individual price targets by roughly CA$2.50 and CA$1, reflecting a mix of optimism and caution among analysts as they reassess assumptions. As you read on, you will see how these evolving targets can help you track the shifting narrative around Vitalhub and what it may mean for your own view of...

Annual Recurring Revenue (“ARR”)⁽¹⁾ up 34% YoY to $99.1 millionTotal Revenue up 47% YoY to $31.9 millionAdjusted EBITDA⁽¹⁾ up 42% YoY to $8.0 million TORONTO, May 07, 2026 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the “Company” or “VitalHub”) announced today it has filed its Interim Condensed Consolidated Financial Statements and Management's Discussion and Analysis report for the three months ended March 31, 2026 with the Canadian securities authorities. These documents may be

TORONTO, May 07, 2026 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the “Company” or “VitalHub”) announced today proposed changes to its Board of Directors (the “Board”) in connection with the Company’s upcoming annual general meeting of shareholders (the “Meeting”) scheduled to be held on June 26, 2026. At the Meeting, management intends to nominate Allan Brett and Andrew Shen for election as directors. Subject to his election, the Board intends to appoint Allan Brett as Chairman

In the midst of a Canadian market characterized by strong corporate earnings and resilient economic fundamentals, investors are keenly observing how these factors offset challenges like higher energy prices and inflation pressures. As the TSX navigates this complex environment, identifying undervalued stocks becomes crucial for those looking to capitalize on potential discounts while maintaining a focus on solid profit growth.

Vitalhub’s recent price target tweaks, generally in the C$1 to C$3 range, suggest that analysts are adjusting their models without abandoning their core view of what the stock could be worth. These moves align with commentary that points to fine tuning around execution and valuation risk, rather than a complete reset of expectations. As you read on, you will see how to interpret these shifts and follow the evolving analyst narrative around Vitalhub. Analyst Price Targets don't always capture...

The Canadian market has been resilient, with strong corporate earnings offsetting challenges from rising energy prices and inflation pressures. As the TSX continues to show robust growth, identifying stocks that may be undervalued becomes crucial for investors looking to capitalize on potential opportunities amidst these favorable economic fundamentals.

As the Canadian market navigates a landscape of steady interest rates and mixed economic signals, including a modest rise in retail spending largely driven by gas prices, investors are keenly watching for opportunities amidst uncertainty. In this environment, identifying stocks that are trading below their intrinsic value can provide a strategic advantage, as these investments may offer potential for growth when broader economic conditions stabilize.